Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01811212
Title Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland cancer

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field